Cross-Tapering from Venlafaxine to Desvenlafaxine

Recommended Cross-Taper Protocol

The Mayo Clinic recommends reducing venlafaxine by approximately 37.5-75 mg every 3-7 days, depending on the starting dose and patient tolerance, while maintaining desvenlafaxine 50 mg daily 1
For patients on venlafaxine 150 mg/day or higher, a slower taper over 2-4 weeks minimizes discontinuation symptoms, according to Praxis Medical Insights 2
Venlafaxine should be tapered gradually because withdrawal syndrome is well-documented with this medication, as noted by the Mayo Clinic Proceedings 1

The Mayo Clinic Proceedings and Praxis Medical Insights recommend obtaining baseline blood pressure before initiating the switch, as venlafaxine causes dose-dependent blood pressure elevations 1, 2
Desvenlafaxine has a more favorable cardiovascular profile than venlafaxine, without significant blood pressure elevation or cardiac conduction effects, according to Praxis Medical Insights 2
Screen for pre-existing cardiac disease, particularly conduction abnormalities, as venlafaxine (but not desvenlafaxine) can cause cardiac conduction problems, as noted by the Mayo Clinic Proceedings and Praxis Medical Insights 1, 2

The entire cross-taper can typically be completed over 1-2 weeks for most patients, according to Praxis Medical Insights 2